ROCK1 and hepatocellular carcinoma: miR-506 inhibits hepatocellular carcinoma (HCC) cell proliferation and tumorigenicity by targeting Rho-associated protein kinase 1 (ROCK1), which is upregulated in HCC tissues and inversely correlated with miR-506 levels, supporting miR-506 mimics as a therapeutic strategy (15).